O

ORIC Pharmaceuticals

86 employees

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Therapeutics
Immunotherapy
Biopharma
Health Care
Oncology
Cancer Resistance

Date founded

2014

Funding rounds raised

Total raised

$85M

from 15 investors over 15 rounds

O

ORIC Pharmaceuticals raised $85M on June 26, 2023

Investors: Nextech Invest

O

ORIC Pharmaceuticals raised $55M on August 9, 2019

Investors: Irving Investors, The Column Group, OrbiMed Advisors, The Invus Group and Foresite Capital

O

ORIC Pharmaceuticals raised $50M on February 21, 2018

Investors: NS Investment, Foresite Capital, The Column Group and OrbiMed Advisors

O

ORIC Pharmaceuticals raised $53M on December 2, 2015

Investors: KKR & Co. Inc., OrbiMed Advisors, Foresite Capital and The Column Group

O

ORIC Pharmaceuticals raised $15M on November 1, 2014

Investors: The Column Group

FAQ